---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-022160"
form_type: "8-K"
ticker: "URGN"
cik: "0001668243"
company_name: "UroGen Pharma Ltd."
filed_at: "2022-09-12T23:59:59+00:00"
generated_at: "2026-06-23T11:07:46.126117+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# UroGen appoints Dr. Leana Wen to board and audit committee

## Summary
- Dr. Wen appointed to fill vacancy; term runs until 2023 annual meeting.
- Received initial option for 20,000 ordinary shares vesting quarterly over 12 quarters.
- Annual retainer of $40,000 for board service plus $7,500 for audit committee.
- Eligible for annual option grant of 10,000 ordinary shares at each shareholder meeting.
- Company entered standard director indemnity agreement with Dr. Wen.

## SEC filing metadata
- accession: 0001437749-22-022160
- form_type: 8-K
- ticker: URGN
- cik: 0001668243
- company_name: UroGen Pharma Ltd.
- filed_at: 2022-09-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668243/000143774922022160/0001437749-22-022160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668243/000143774922022160/urgn20220909_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-022160
- JSON: https://secwatch.observer/filing/0001437749-22-022160.json
- Plain text: https://secwatch.observer/filing/0001437749-22-022160.txt

## Key facts
- Executive change
  Leana Wen was appointed as Director at UroGen Pharma Ltd..
  - Action: appointed
  - Role: Director
  source text: On September 8, 2022, Leana Wen, M.D., MSc was appointed to the board of directors (the “Board”) of UroGen Pharma Ltd., an Israeli company (the “Company”), to fill a vacancy on the Board and to hold office until the Company’s 2023 Annual Meeting of Shareholders and was also appointed to the Audit Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000143774922022160/0001437749-22-022160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.